preclampsia - Nursing Case Study
Pathophysiology
• Primary mechanism: Abnormal placentation leads to defective remodeling of spiral arteries, causing them to remain narrow and high-resistance, which reduces placental blood flow and triggers systemic endothelial dysfunction.
• Secondary mechanism: Endothelial dysfunction results in widespread vasoconstriction and increased vascular permeability, contributing to hypertension and proteinuria.
• Key complication: This cascade can progress to multi-organ damage, notably affecting the liver, kidneys, and central nervous system, posing significant risks to both maternal and fetal health if not managed promptly.
Patient Profile
Demographics:
28-year-old female, teacher
History:
• Key past medical history: Gestational hypertension in previous pregnancy, hypothyroidism
• Current medications: Levothyroxine 100 mcg daily, prenatal vitamins
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and visual disturbances
• Key symptoms: Swelling in hands and face, increased fatigue, upper abdominal pain
• Vital signs: Blood pressure 150/100 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F
Section 1
As the clinical team conducts an initial assessment, the patient's condition is further evaluated with a thorough physical examination and additional diagnostics. On examination, she exhibits bilateral pitting edema in her lower extremities and facial puffiness, consistent with her reported swelling. Auscultation of the lungs reveals mild basilar crackles, suggesting possible fluid overload. A fundoscopic exam of the eyes identifies retinal changes, including arteriolar narrowing and hemorrhages, correlating with her complaint of visual disturbances.
Laboratory tests are promptly ordered to assess the extent of organ involvement. Results reveal proteinuria with a urine protein-to-creatinine ratio of 0.4, indicating significant renal involvement. Liver function tests show elevated transaminases, with AST and ALT levels at 85 U/L and 92 U/L, respectively, hinting at hepatic stress or damage. Platelet count is slightly reduced at 120,000/mm³, raising concerns about potential progression to HELLP syndrome. Creatinine levels are within the upper normal range at 1.1 mg/dL, warranting close monitoring for potential renal impairment.
These findings prompt the healthcare team to consider escalation in management. The elevated blood pressure, proteinuria, and lab abnormalities suggest the progression of preeclampsia with potential for more severe complications. Management strategies are adjusted to include antihypertensive therapy with labetalol and magnesium sulfate for seizure prophylaxis. The obstetric team discusses the possibility of expedited delivery, weighing the risks and benefits due to the potential for rapid deterioration of both maternal and fetal status. Ongoing monitoring of maternal and fetal wellbeing is prioritized to swiftly identify any further changes in the patient's condition. This evolving scenario necessitates vigilant clinical reasoning to anticipate and mitigate further complications.
Section 2
As the clinical team continues to monitor the patient closely, they observe a change in her status that necessitates immediate attention. The patient's blood pressure, previously managed at 150/95 mmHg with labetalol, has risen to 165/110 mmHg despite the antihypertensive therapy, indicating a potential escalation in the severity of her preeclampsia. In addition to the rising blood pressure, the patient begins to report new symptoms of epigastric pain and persistent headaches, which are concerning for worsening preeclampsia or impending eclampsia.
In response to these changes, the clinical team decides to increase the dosage of labetalol and continues the magnesium sulfate infusion for seizure prophylaxis. Blood tests are repeated to evaluate any progression in organ dysfunction. The results reveal a further decline in platelet count to 105,000/mm³, and the liver enzyme levels have risen to AST of 110 U/L and ALT of 125 U/L. These findings suggest an increased risk of developing HELLP syndrome, a severe form of preeclampsia with hemolysis, elevated liver enzymes, and low platelet count, requiring the team to consider more aggressive management strategies.
Given the patient's deteriorating condition and the potential risks to both mother and fetus, the obstetric team decides to expedite delivery. The decision is made to proceed with induction of labor, considering the gestational age and fetal status. Continuous fetal monitoring is implemented to assess for any signs of fetal distress, and the patient is moved to labor and delivery for closer observation and intervention. This approach aims to prevent further complications and optimize outcomes for both the patient and her unborn child, highlighting the critical importance of timely decision-making in the management of severe preeclampsia.
Section 3
As the patient is moved to the labor and delivery unit, the clinical team performs an initial assessment to establish her current status and baseline. The patient's vital signs show a sustained elevated blood pressure at 170/115 mmHg, and she continues to report severe frontal headaches and worsening epigastric pain. On physical examination, the patient appears visibly anxious and uncomfortable, with mild facial edema and hyperreflexia noted. The fetal heart rate monitor indicates a baseline fetal heart rate of 150 beats per minute, with occasional decelerations suggestive of intermittent fetal distress.
In light of these findings, the team reviews the results of the latest laboratory tests, which provide further insight into the patient's deteriorating condition. The platelet count has decreased further to 95,000/mm³, confirming the progression toward HELLP syndrome. Additionally, the patient's renal function tests reveal an elevated creatinine level of 1.4 mg/dL, indicating possible kidney involvement. These diagnostic results underscore the urgency of the situation, prompting the team to reevaluate the current plan and consider further interventions to stabilize the patient while proceeding with labor induction.
The response to the increased dosage of labetalol and magnesium sulfate infusion is closely monitored. Despite these interventions, the patient's blood pressure remains high, with minimal improvement in her headache and epigastric pain. Given the lack of response and the concerning lab results, the obstetric team discusses the possibility of transitioning to a cesarean delivery if labor induction does not progress promptly or if fetal distress worsens. This decision reflects the need to balance the risks to the mother with the imperative to ensure a safe delivery for the baby, emphasizing the critical role of continuous assessment and adaptability in managing severe preeclampsia.
Section 4
As the team continues to monitor the patient's condition, a noticeable change in her status emerges. The patient begins experiencing increased respiratory distress, characterized by a respiratory rate that has escalated to 28 breaths per minute, with shallow breaths and audible wheezing. Auscultation reveals crackles at the lung bases, suggesting the development of pulmonary edema, a complication associated with severe preeclampsia and fluid overload from magnesium sulfate therapy. This respiratory compromise adds a new layer of urgency to the clinical picture, necessitating immediate intervention to prevent further deterioration.
The decision is made to administer supplemental oxygen via a non-rebreather mask to improve oxygenation, with continuous pulse oximetry monitoring revealing an initial saturation level of 88%. The team adjusts the patient's position to semi-Fowler's to facilitate lung expansion and enhance respiratory function. Concurrently, the obstetrician consults with the anesthesiology and neonatology teams to prepare for a potential emergent cesarean delivery, as the fetal heart rate monitor shows increased variability and more frequent decelerations, indicating worsening fetal distress. This multifaceted approach underscores the critical need for comprehensive care coordination and swift clinical decision-making to optimize outcomes for both mother and baby.
The patient's symptoms and lab results prompt a reassessment of her fluid balance and medication regimen. Diuretics are cautiously considered to manage the pulmonary edema, while the magnesium sulfate infusion is carefully titrated to mitigate the risk of magnesium toxicity. Throughout this process, the nursing team plays a pivotal role in conducting frequent assessments, ensuring effective communication among the multidisciplinary team, and providing essential support to the patient and her family during this intensely challenging time. As the situation evolves, the healthcare team remains vigilant, ready to adapt to the dynamic clinical scenario to ensure the safety and well-being of the patient and her unborn child.
Section 5
As the clinical team continues to manage the patient's condition, new diagnostic results provide additional insight into her complex clinical picture. Laboratory tests reveal a serum magnesium level of 4.8 mg/dL, approaching the upper therapeutic range, raising concerns about potential magnesium toxicity. Concurrently, the patient's urine output has diminished to 20 mL/hr, indicating possible renal compromise and necessitating careful reevaluation of her fluid and electrolyte balance. Blood pressure remains elevated at 165/110 mmHg, despite the administration of antihypertensive medications, highlighting the persistent severity of her preeclampsia.
The fetal non-stress test shows persistent late decelerations, with the baseline fetal heart rate dropping to 100 beats per minute, suggesting ongoing fetal distress. These findings prompt the obstetrician to expedite the decision for an emergency cesarean delivery, prioritizing the safety of both mother and child. Meanwhile, the nursing team focuses on meticulous monitoring of the patient's neurological status, as she begins to exhibit hyperreflexia and clonus, further signs of magnesium toxicity.
In response to these developments, the team acts swiftly to adjust the patient's medication regimen. A bolus of calcium gluconate is prepared as a precautionary measure to counteract potential magnesium toxicity, while diuretics are administered judiciously to address fluid overload and support renal function. Throughout these interventions, the nursing team maintains vigilant assessment, ensuring the patient receives optimal care as she is prepared for the operating room. This thorough coordination underscores the critical nature of timely and informed decision-making in managing severe preeclampsia and its complications.